Edition:
United States

pSivida Corp (PSDV.OQ)

PSDV.OQ on NASDAQ Stock Exchange Global Market

1.77USD
21 Apr 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.77
Open
$1.79
Day's High
$1.80
Day's Low
$1.75
Volume
41,728
Avg. Vol
31,938
52-wk High
$4.23
52-wk Low
$1.50

PSDV.OQ

Chart for PSDV.OQ

About

pSivida Corp. develops drug delivery products primarily for the treatment of chronic eye diseases. The Company operates through the biotechnology sector segment. The Company has developed three products for treatment of back-of-the-eye diseases, which include Medidur for posterior segment uveitis, its lead product candidate that... (more)

Overall

Beta: 1.41
Market Cap(Mil.): $60.49
Shares Outstanding(Mil.): 34.18
Dividend: --
Yield (%): --

Financials

  PSDV.OQ Industry Sector
P/E (TTM): -- 57.54 29.95
EPS (TTM): -0.55 -- --
ROI: -106.96 -0.41 13.21
ROE: -127.85 6.21 14.38

BRIEF-Rosalind Advisors reports 6.2 pct passive stake in pSivida as of April 5 - SEC filing

* Rosalind Advisors Inc reports a 6.2 percent passive stake in pSivida Corp as of April 5 - SEC filing Source text : (http://bit.ly/2oNkBw7) Further company coverage:

Apr 07 2017

BRIEF-pSivida Corp says entered into an at market issuance sales agreement with FBR Capital Markets & Co to create an at market equity program

* pSivida Corp says entered into an at market issuance sales agreement with FBR Capital Markets & Co to create an at market equity program

Feb 08 2017

BRIEF-PSivida Corp posts Q1 loss per share $0.21

* Psivida Corp reports fiscal 2017 first quarter results and provides update on corporate objectives & milestone timeline

Nov 07 2016

More From Around the Web

Earnings vs. Estimates